{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T16:10:20Z","timestamp":1778083820361,"version":"3.51.4"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The role of repeat kidney biopsy in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) with suspected renal relapse remains uncertain. Clinical indicators such as hematuria, proteinuria and ANCA reappearance often guide therapy but may not reliably distinguish active vasculitis from chronic damage. Repeat biopsy may also provide prognostic information in patients with prolonged immunosuppressive exposure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed adults with biopsy-proven AAV who underwent a second kidney biopsy (KB2) for suspected renal relapses. Clinical, laboratory and histopathologic data from the first (KB1) and KB2 were reviewed. Dynamic variations in ANCA, hematuria and proteinuria between 6 months post-KB1 and -KB2 were assessed for their association with histologic activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Forty patients were included; 25 (62%) had histologically active vasculitis on KB2, whereas 15 (38%) showed inactive lesions. Active disease was associated with the presence (P\u00a0=\u00a0.001) and higher levels of hematuria [100 (92\u2013100) vs 14 (4\u201346) cells\/mm\u00b3, P\u00a0&amp;lt;\u00a0.0001] and proteinuria [1.55 (1.0\u20133.30) vs 0.89 (0.44\u20131.53) g\/g, P\u00a0=\u00a0.046]. Longitudinally, ANCA and hematuria reappearance were associated with active vasculitis in 68% and 80% of cases, respectively, whereas proteinuria rise was not. Repeat biopsies showed a shift from proliferative to sclerotic lesions, with increased glomerulosclerosis and interstitial fibrosis; the degree of glomerulosclerosis inversely correlated with renal recovery at 6 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Clinical and laboratory findings alone often overestimate renal relapses. Dynamic changes in ANCA and hematuria improve prediction but remain insufficient to replace biopsy confirmation, which provides essential diagnostic and prognostic information in relapsing AAV.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ckj\/sfag026","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T12:50:34Z","timestamp":1770209434000},"source":"Crossref","is-referenced-by-count":0,"title":["Repeat kidney biopsy in patients with ANCA-associated vasculitis and suspected kidney relapse"],"prefix":"10.1093","volume":"19","author":[{"given":"Pierre","family":"Braud","sequence":"first","affiliation":[{"name":"University Hospital of Nantes Department of Nephrology and Immunology, , Nantes ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice Le","family":"Clech","sequence":"additional","affiliation":[{"name":"Saint Nazaire Hospital Department of Nephrology, , Saint Nazaire ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gr\u00e9goire","family":"Couvrat-Desvergnes","sequence":"additional","affiliation":[{"name":"Departmental Hospital of Vend\u00e9e Department of Nephrology and Dialysis, , La Roche-sur-Yon ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jer\u00f4me","family":"Dimet","sequence":"additional","affiliation":[{"name":"Clinical Research Unit, Departmental Hospital of Vend\u00e9e , La Roche-sur-Yon ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Moreau","sequence":"additional","affiliation":[{"name":"Departmental Hospital of Vend\u00e9e Department of Pathology, , La Roche-sur-Yon ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Renaudin","sequence":"additional","affiliation":[{"name":"University hospital of Nantes Department of Pathology, , Nantes ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Benard","sequence":"additional","affiliation":[{"name":"Saint Nazaire Hospital Department of Pathology, , Saint Nazaire ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"N\u00e9el","sequence":"additional","affiliation":[{"name":"University hospital of Nantes Department of Internal Medicine, , Nantes ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0618-6187","authenticated-orcid":false,"given":"Simon","family":"Ville","sequence":"additional","affiliation":[{"name":"University Hospital of Nantes Department of Nephrology and Immunology, , Nantes ,","place":["France"]},{"name":"Centre de Recherche en Transplantation et Immunologie UMR 1064, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), Universit\u00e9 de Nantes , Nantes ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Ronsin","sequence":"additional","affiliation":[{"name":"Departmental Hospital of Vend\u00e9e Department of Nephrology and Dialysis, , La Roche-sur-Yon ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"2026050611115440300_bib1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0140-6736(23)01736-1","article-title":"Diagnosis and management of ANCA-associated vasculitis","volume":"403","author":"Kronbichler","year":"2024","journal-title":"Lancet"},{"key":"2026050611115440300_bib2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"2026050611115440300_bib3","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the treatment of ANCA-associated vasculitis","volume":"384","author":"Jayne","year":"2021","journal-title":"N Engl J Med"},{"key":"2026050611115440300_bib4","doi-asserted-by":"publisher","first-page":"rkab018","DOI":"10.1093\/rap\/rkab018","article-title":"Predicting relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis: a systematic review and meta-analysis","volume":"5","author":"King","year":"2021","journal-title":"Rheumatol Adv Pract"},{"key":"2026050611115440300_bib5","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.2215\/CJN.01020113","article-title":"Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis","volume":"8","author":"de Joode","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026050611115440300_bib6","doi-asserted-by":"crossref","first-page":"Suppl 1:i150\u2013158","DOI":"10.1093\/ndt\/gfu397","article-title":"Maintenance therapy in antineutrophil cytoplasmic antibody-associated vasculitis: who needs what and for how long?","volume":"30","author":"de Joode","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2026050611115440300_bib7","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.kint.2023.10.008","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group. KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"2026050611115440300_bib8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2026050611115440300_bib9","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1681\/ASN.2021030382","article-title":"The clinical application of urine soluble CD163 in ANCA-associated vasculitis","volume":"32","author":"Moran","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2026050611115440300_bib10","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.2215\/CJN.07210520","article-title":"Urinary soluble CD163 and disease activity in biopsy-proven ANCA-associated glomerulonephritis","volume":"15","author":"Aendekerk","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026050611115440300_bib11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/ndt\/gfy018","article-title":"Urinary and serum soluble CD25 complements urinary soluble CD163 to detect active renal anti-neutrophil cytoplasmic autoantibody-associated vasculitis: a cohort study","volume":"34","author":"Dekkema","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"2026050611115440300_bib12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1681\/ASN.0000000000000311","article-title":"Urinary CD4 + T cells predict renal relapse in ANCA-associated vasculitis","volume":"35","author":"Prskalo","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"2026050611115440300_bib13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/MD.0b013e3181c101cc","article-title":"Persistent hematuria after induction of remission in Wegener granulomatosis: a therapeutic dilemma","volume":"88","author":"Magrey","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"2026050611115440300_bib14","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.3899\/jrheum.111608","article-title":"Persistent or new onset microscopic hematuria in patients with small vessel vasculitis in remission: findings on renal biopsy","volume":"39","author":"Geetha","year":"2012","journal-title":"J Rheumatol"},{"key":"2026050611115440300_bib15","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1093\/rheumatology\/keab695","article-title":"Utility of interval kidney biopsy in ANCA-associated vasculitis","volume":"61","author":"Chapman","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2026050611115440300_bib16","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.ekir.2023.07.021","article-title":"Repeat kidney biopsies in anti-neutrophil cytoplasmic autoantibody-associated vasculitis: clinical and histologic progression","volume":"8","author":"Aqeel","year":"2023","journal-title":"Kidney Int Rep"},{"key":"2026050611115440300_bib17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/rheumatology\/ker280","article-title":"Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis\u2014a meta-analysis","volume":"51","author":"Tomasson","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"2026050611115440300_bib18","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/ndt\/17.4.587","article-title":"Long-term renal injury in ANCA-associated vasculitis: an analysis of 31 patients with follow-up biopsies","volume":"17","author":"Hauer","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"2026050611115440300_bib19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ndt\/gfh563","article-title":"Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis","volume":"20","author":"Neumann","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"2026050611115440300_bib20","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1093\/ndt\/gfu042","article-title":"Repeat protocol renal biopsy in ANCA-associated renal vasculitis","volume":"29","author":"Hruskova","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"2026050611115440300_bib21","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1053\/j.ajkd.2016.09.002","article-title":"AJKD atlas of renal pathology: pauci-immune necrotizing crescentic glomerulonephritis","volume":"68","author":"Fogo","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2026050611115440300_bib22","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis Activity Score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2026050611115440300_bib23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/ckj\/sfs160","article-title":"The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review","volume":"6","author":"Lopes","year":"2013","journal-title":"Clin Kidney J"},{"key":"2026050611115440300_bib24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"2026050611115440300_bib25","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1681\/ASN.2010050477","article-title":"Histopathologic classification of ANCA-associated glomerulonephritis","volume":"21","author":"Berden","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"2026050611115440300_bib26","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.kint.2018.07.020","article-title":"Development and validation of a renal risk score in ANCA-associated glomerulonephritis","volume":"94","author":"Brix","year":"2018","journal-title":"Kidney Int"},{"key":"2026050611115440300_bib27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2215\/CJN.04160417","article-title":"The utility of urinalysis in determining the risk of renal relapse in ANCA-associated vasculitis","volume":"13","author":"Rhee","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026050611115440300_bib28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/annrheumdis-2013-203927","article-title":"Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials","volume":"74","author":"Robson","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2026050611115440300_bib29","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.kint.2023.02.029","article-title":"Proteinuria and hematuria after remission induction are associated with outcome in ANCA-associated vasculitis","volume":"103","author":"Benichou","year":"2023","journal-title":"Kidney Int"},{"key":"2026050611115440300_bib30","doi-asserted-by":"publisher","first-page":"sfae379","DOI":"10.1093\/ckj\/sfae379","article-title":"Albuminuria after induction treatment and kidney prognosis in ANCA-associated glomerulonephritis","volume":"18","author":"Chalkia","year":"2025","journal-title":"Clin Kidney J"},{"key":"2026050611115440300_bib31","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1136\/ard.2008.094714","article-title":"Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides","volume":"68","author":"Terrier","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2026050611115440300_bib32","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.kint.2024.10.018","article-title":"Lupus nephritis: redefining the treatment goals","volume":"107","author":"Vriese","year":"2025","journal-title":"Kidney Int"},{"key":"2026050611115440300_bib33","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1681\/ASN.2016070776","article-title":"A proposal for a serology-based approach to membranous nephropathy","volume":"28","author":"De Vriese","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2026050611115440300_bib34","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1681\/ASN.0000000912","article-title":"How to cure autoimmune glomerulonephritis and podocytopathies","volume":"37","author":"Anders","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"2026050611115440300_bib35","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1172\/JCI0215918","article-title":"Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice","volume":"110","author":"Xiao","year":"2002","journal-title":"J Clin Invest"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag026\/66788462\/sfag026.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/3\/sfag026\/66788462\/sfag026.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/3\/sfag026\/66788462\/sfag026.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T15:12:00Z","timestamp":1778080320000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag026\/8465376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag026","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,2,5]]},"article-number":"sfag026"}}